Immune Thrombocytopenic Purpura Associated With Pfizer-BioNTech COVID-19 Vaccine Refractory to Conventional Treatment

Authors

Ghulam Ghous
Muhammad Usman Zafar MD, Lehigh Valley Health NetworkFollow
Zahid Ijaz Tarar
Hafiz Muhammad Hassan

Publication/Presentation Date

7-2021

Volume

28

Issue

4

First Page

e521

Last Page

e522

Published In/Presented At

Ghous, G., Allahyar, Zafar, M.U., Tarar, Z.I., & Hafiz, M.H. (2021). Immune thrombocytopenic purpura associated with Pfizer-BioNTech COVID-19 vaccine refractory to conventional treatment. American Journal of Therapeutics, 28(4), pp. e521-e522.

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article